Analyst Upgrades

• Procter & Gamble (PG) upgraded to buy from neutral at Goldman.
• Capital One (COF) upgraded to outperform from market perform at FBR Capital.
• Airgas (ARG) upgraded to outperform from neutral at RW Baird.
• Broadcom (BRCM) upgraded to positive from neutral at Susquehanna.
• Lululemon (LULU) upgraded to hold from underperform at Jefferies.
• DryShips (DRYS) upgraded to outperform from neutral at Credit Suisse.

Analyst Upgrades

• Verisk (VRSK) was upgraded to outperform from market perform at Wells Fargo.
• Marriott (MAR) was upgraded to outperform from market perform at Bernstein.
• Jefferies upgraded Teekay (TK) and Tsakos Energy (TNP) to Buy from Hold.
• Cadence Design (CDNS) was upgraded to sector perform from underperform at RBC Capital.
• BofA/Merrill upgraded NV Energy (NVE) to buy from underperform and Education Realty Trust (EDR) to neutral from underperform.
• Men's Wearhouse (MW) was upgraded to buy from hold at Stifel.
• William Blair upgraded Atheros (ATHR) to outperform from market perform.
• Freeport McMoran (FCX) was upgraded to buy from hold at Argus.

Analyst Upgrades

• UBS upgraded Boeing (BA) to neutral from sell, citing increased delivery forecasts. The firm raised its target to $68 from $50.
• Benchmark Co. upgraded Meredith Corp. (MDP) to buy from hold to reflect improving broadcasting and magazine advertising fundamentals. The firm raised its target for shares to $40 from $36.
• Keefe Bruyette upgraded Transatlantic (TRH) to market perform from underperform after the annual statutory data was published. The firm raised its target for shares to $51 from $4.
• Disney (DIS) was upgraded to buy from neutral at BofA/Merrill.
• Royal Caribbean (RCL) was upgraded to neutral from sell at Goldman.
• FedEx (FDX) was upgraded to outperform from market perform at Morgan Keegan.

Analyst Upgrades

• Jefferies upgraded Citrix Systems (CTXS) to buy from hold and raised its target to $48 from $43, citing VMware's (VMW) strong Q4 report and survey results that indicate continued strength for Citrix.
• Citigroup upgraded Amylin Pharmaceuticals (AMLN) to buy from hold on confidence the company's LAR drug will be approved following the approval of Novo Nordisk's (NVO) Victoza. Citi raised its target price for Amylin shares to $27 from $4.
• Baird upgraded Texas Instruments (TXN) to outperform from neutral and raised its target to $30 from $28. The firm believes it is too early to take profits in Texas Instruments and notes that checks continue to indicate a continued recovery in end-demand.
• Lexmark (LXK) was upgraded to overweight from equal weight at Barclays.
• Salix (SLXP) was upgraded to outperform from perform at Oppenheimer.
• Plexus (PLXS) was lifted to outperform from neutral at Credit Suisse.

Analyst Upgrades

• Citigroup upgraded JPMorgan (JPM) to buy from hold on valuation as it finds the risk/reward on shares attractive following yesterday's sell-off. Citi keeps a $48 price target on the stock.
• Oppenheimer upgraded International Game Tech (IGT) to outperform from perform as it believes fundamentals for slot suppliers will improve over the next two years. The firm has a $29 price target on the stock.
• SunTrust believes Perry Ellis (PERY) is now positioned to deliver stronger margins and significant reductions in charge-backs. Shares were upgraded to buy from neutral.
• Nordstrom (JWN) was upgraded to neutral from underperform at BofA/Merrill.
• Tyson Foods (TSN) was upgraded to buy from hold at BB&T.
• Consol Energy (CNX) was upgraded to buy from neutral at Goldman.

Analyst Upgrades

• Keefe Bruyette upgraded Jefferies (JEF) to outperform from market perform based on valuation and improved M&A advisory and underwriting prospects. The firm has a $30 target on the shares.
• JPMorgan upgraded Cosan (CZZ) to overweight from neutral based on valuation.The firm has a $10 target on shares.
• Deutsche Bank upgraded CTC Media (CTCM) to buy from hold, citing better-than-expected operational performance and the impact of recent ad law changes. The firm has a $17 target on shares.